Gahyun Gim

Gahyun Gim, MD

Clinical Assistant Professor

Department: MD-HEMATOLOGY-ONCOLOGY-OTHER
Business Phone: (352) 273-7832
Business Email: ggim@ufl.edu

On This Page

About Gahyun Gim

I work as a hematology and oncology specialist here at UF Health and am board certified in internal medicine by the American Board of Internal Medicine. My position at UF Health was preceded by an educational journey that started in Busan, South Korea, where I received my medical degree in 2015 from the Kosin University College of Medicine . I continued my medical education in 2018 with a residency in internal medicine at St. Elizabeth’s Medical Center in Boston , then affiliated with Tufts University School of Medicine. After this residency, I completed a fellowship in hematology and medical oncology at the Wilmot Cancer Center at the University of Rochester Medical Center in New York .

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine

Clinical Profile

Specialties

  • Hematology and Oncology

Publications

Academic Articles

  1. Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.

    Journal
    The oncologist.
    Volume/Issue
    27(7):525-531
    [DOI]
    10.1093/oncolo/oyac095.
    [PMID]
    35640145.
  2. Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.

    Journal
    The oncologist.
    Volume/Issue
    27(6):e471-e483
    [DOI]
    10.1093/oncolo/oyac036.
    [PMID]
    35348765.
  3. Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy.

    Journal
    Heliyon.
    Volume/Issue
    7(9)
    [DOI]
    10.1016/j.heliyon.2021.e07916.
    [PMID]
    34568594.
  4. Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.

    Journal
    Translational lung cancer research.
    Volume/Issue
    10(4):1700-1710
    [DOI]
    10.21037/tlcr-20-933.
    [PMID]
    34012786.
  5. Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).

    Journal
    Cancer immunology, immunotherapy : CII.
    Volume/Issue
    70(4):961-965
    [DOI]
    10.1007/s00262-020-02703-8.
    [PMID]
    33084943.

Grants

  1. BillionToOne<>University of Florida GI Oncology Group Study Collaboration Proposal

    Active

    Role:
    Co-Project Director/Principal Investigator
    Funding:
    BILLIONTOONE

Education

  1. Fellowship, Hematology and Medical Oncology

    Wilmot Cancer Center, University of Rochester Medical Center

  2. Residency, Internal Medicine

    Tufts University School of Medicine/St. Elizabeth’s Medical Center

  3. Medical Degree

    Kosin University College of Medicine

Contact Details

Phones:
Business:
(352) 273-7832
Emails:
Business:
ggim@ufl.edu
Addresses:
Business Street:
PO Box 100278
GAINESVILLE FL 32611